Skip to Content
Merck
All Photos(2)

Key Documents

GF40940153

Bismuth

foil, not light tested, 25x25mm, thickness 0.01mm, permanent polyester support, 99.97%

Synonym(s):

Bismuth, BI000120

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
Bi
CAS Number:
Molecular Weight:
208.98
MDL number:
UNSPSC Code:
12141706
PubChem Substance ID:
NACRES:
NA.23

Pricing and availability is not currently available.

vapor pressure

<0.1 mmHg ( 20 °C)

Assay

99.97%

form

foil

manufacturer/tradename

Goodfellow 409-401-53

resistivity

129 μΩ-cm, 20°C

bp

1560 °C (lit.)

mp

271 °C (lit.)

density

9.8 g/mL at 25 °C (lit.)

SMILES string

[Bi]

InChI

1S/Bi

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
GF21124561GF12515891GF05789425
manufacturer/tradename

Goodfellow 409-401-53

manufacturer/tradename

Goodfellow 211-245-61

manufacturer/tradename

Goodfellow 125-158-91

manufacturer/tradename

Goodfellow 057-894-25

form

foil

form

foil

form

foil

form

foil

mp

271 °C (lit.)

mp

271 °C (lit.)

mp

271 °C (lit.)

mp

271 °C (lit.)

density

9.8 g/mL at 25 °C (lit.)

density

9.8 g/mL at 25 °C (lit.)

density

9.8 g/mL at 25 °C (lit.)

density

9.8 g/mL at 25 °C (lit.)

bp

1560 °C (lit.)

bp

1560 °C (lit.)

bp

1560 °C (lit.)

bp

1560 °C (lit.)

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Alexander C Ford et al.
World journal of gastroenterology, 14(48), 7361-7370 (2008-12-26)
To assess the safety of bismuth used in Helicobacter pylori (H pylori) eradication therapy regimens. We conducted a systematic review and meta-analysis. MEDLINE and EMBASE were searched (up to October 2007) to identify randomised controlled trials comparing bismuth with placebo
Hongyan Li et al.
Current opinion in chemical biology, 16(1-2), 74-83 (2012-02-11)
Bismuth has been used in medicine for over two centuries for the treatment of various diseases, in particular for gastrointestinal disorders, owing to its antimicrobial activity. Recent structural characterization of bismuth drugs provides an insight into assembly and pharmacokinetic pathway
Emma Aneheim et al.
Scientific reports, 5, 12025-12025 (2015-07-15)
To facilitate multicentre clinical studies on targeted alpha therapy, it is necessary to develop an automated, on-site procedure for conjugating rare, short-lived, alpha-emitting radionuclides to biomolecules. Astatine-211 is one of the few alpha-emitting nuclides with appropriate chemical and physical properties
Bismuth in medicine.
Hongzhe Sun et al.
Metal ions in biological systems, 41, 333-378 (2004-06-23)
Ruiguang Ge et al.
Metallomics : integrated biometal science, 4(3), 239-243 (2012-02-24)
Helicobacter pylori causes various gastric diseases, such as gastritis, peptic ulcerations and gastric cancer. Bismuth-based triple or quadruple therapies have been commonly recommended for the treatment of H. pylori infections. Up to now, the molecular mechanisms by which bismuth inhibits

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service